- Home
- CLLS
CLLS
Cellectis S.A.
as 07-31-2025 4:00pm EST
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Upcoming Earnings Alert:
Get ready for potential market movements as Cellectis S.A. CLLS prepares to release earnings report on 04 Aug 2025.
| Founded: | 1999 | Country: | France |
| Employees: | N/A | City: | N/A |
| Market Cap: | 143.4M | IPO Year: | 2007 |
| Target Price: | $4.00 | AVG Volume (30 days): | 285.0K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.62 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.10 - $3.10 | Next Earning Date: | 08-04-2025 |
| Revenue: | $54,747,000 | Revenue Growth: | 351.26% |
| Revenue Growth (this year): | -7.49% | Revenue Growth (next year): | 4.90% |
Latest Cellectis S.A. News
CLLS Breaking Stock News: Dive into CLLS Ticker-Specific Updates for Smart Investing
MT Newswires
14 days ago
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
MT Newswires
15 days ago
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
MT Newswires
16 days ago
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
MT Newswires
17 days ago
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
MT Newswires
18 days ago
European Equities Traded in the US as ADRs Edge Up in Monday Trading
GlobeNewswire
a month ago
Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025
MT Newswires
a month ago
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
Simply Wall St.
a month ago
European Penny Stocks To Watch In June 2025
Compare CLLS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLLS Cellectis S.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.